Zojwalla Naseem, Chief Medical Officer of Olema Pharmaceuticals ($OLMA), sold shares on the open market four times in the last year, totaling $7.5 million. Her most recent sale occurred on December 23, 2025. These $OLMA insider sales rank 1,413th among 11,678 individuals in our database, below the average sale amount of $8.6 million across 6.4 transactions. Naseem made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 85,732,221 | 9999.99% | 0.29% |
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Performance Stock Options (Right to Buy) | 106250 | $0.00 | 106,250.0000 | 85,732,221 | 9999.99% | 0.12% |
| Dec. 22, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Stock Option (Right to Buy) | 7182 | $0.00 | 206,818.0000 | 85,732,221 | 3.36% | 0.01% |
| Dec. 22, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Stock Option (Right to Buy) | 42818 | $0.00 | 112,182.0000 | 85,732,221 | 27.62% | 0.05% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Stock Option (Right to Buy) | 40000 | $0.00 | 155,000.0000 | 85,732,221 | 20.51% | 0.05% |
| Dec. 23, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | S | Common Stock | 99509 | $27.66 | 4,488.0000 | 85,732,221 | 95.68% | 0.12% |
| Dec. 23, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Common Stock | 50000 | $7.02 | 103,997.0000 | 85,732,221 | 92.60% | 0.06% |
| Dec. 22, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | S | Common Stock | 100000 | $28.04 | 53,997.0000 | 85,732,221 | 64.94% | 0.12% |
| Dec. 22, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Common Stock | 7182 | $7.02 | 153,997.0000 | 85,732,221 | 4.89% | 0.01% |
| Dec. 22, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Common Stock | 42818 | $15.25 | 146,815.0000 | 85,732,221 | 41.17% | 0.05% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | S | Common Stock | 12921 | $28.93 | 103,997.0000 | 85,732,221 | 11.05% | 0.02% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Common Stock | 40000 | $15.25 | 173,997.0000 | 85,732,221 | 29.85% | 0.05% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | S | Common Stock | 57079 | $28.03 | 116,918.0000 | 85,732,221 | 32.80% | 0.07% |
| Dec. 23, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 156,818.0000 | 85,732,221 | 24.18% | 0.06% |
| Feb. 28, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 205000 | $0.00 | 205,000.0000 | 58,743,522 | 9999.99% | 0.35% |
| Dec. 16, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 14000 | $4.87 | 129,509.0000 | 57,262,803 | 12.12% | 0.02% |
| Dec. 16, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 14000 | $0.00 | 112,840.0000 | 57,262,803 | 11.04% | 0.02% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 320 | $9.39 | 115,509.0000 | 57,262,803 | 0.28% | 0.00% |
| Dec. 9, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Common Stock | 52000 | $0.00 | 143,314.0000 | 57,262,803 | 56.95% | 0.09% |
| Dec. 10, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 13283 | $9.37 | 130,031.0000 | 57,262,803 | 9.27% | 0.02% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 14202 | $8.66 | 115,829.0000 | 57,262,803 | 10.92% | 0.02% |
| May 24, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 9460 | $4.87 | 89,824.0000 | 45,247,098 | 11.77% | 0.02% |
| May 24, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 9460 | $0.00 | 126,840.0000 | 45,247,098 | 6.94% | 0.02% |
| March 18, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 13700 | $4.87 | 80,364.0000 | 45,247,098 | 20.55% | 0.03% |
| March 18, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 13700 | $0.00 | 136,300.0000 | 45,247,098 | 9.13% | 0.03% |
| Feb. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 45,247,098 | 9999.99% | 0.43% |
| Jan. 25, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 20000 | $7.02 | 66,664.0000 | 45,247,098 | 42.86% | 0.04% |
| Jan. 25, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 20000 | $0.00 | 214,000.0000 | 45,247,098 | 8.55% | 0.04% |
| Dec. 11, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 2900 | $0.00 | 234,000.0000 | 0 | 1.22% | 0.00% |
| Dec. 11, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 2900 | $7.02 | 46,664.0000 | 0 | 6.63% | 0.00% |
| Dec. 6, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Common Stock | 13100 | $7.02 | 43,764.0000 | 0 | 42.72% | 0.00% |
| Dec. 6, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 13100 | $0.00 | 236,900.0000 | 0 | 5.24% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 200 | $15.33 | 37,759.0000 | 0 | 0.53% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 7261 | $14.83 | 37,959.0000 | 0 | 16.06% | 0.00% |
| Nov. 20, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | A | Common Stock | 28000 | $0.00 | 45,220.0000 | 0 | 162.60% | 0.00% |
| Nov. 22, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S | Common Stock | 7095 | $13.89 | 30,664.0000 | 0 | 18.79% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Zojwalla Naseem | Chief Medical Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |